A female pt 60 y ckd 5 on mhd from 6 months recently complaining of bo

A female pt 60 y ckd 5 on mhd from 6 months recently complaining of body pain with no fever, mostly back pain ,h/o of htn, tachycardia,t2dm, fluid overload ,access av fistula and permacath , prescribe medicine properly on indian based company, and suggest investigation

Reading File

Finding Sources

Searching PubMed

"hemodialysis catheter" AND "bloodstream infection"

Searching the Web

Indian brand names cinacalcet sevelamer calcitriol phosphate binder CKD hemodialysis

Clinical Assessment – CKD-5 on MHD, Afebrile Back/Body Pain with Tachycardia and Fluid Overload

This presentation needs a cause-first approach before finalizing analgesia — back pain in a diabetic MHD patient with a permacath, even without fever, is a red flag for catheter-related infection/discitis until proven otherwise, since uremic and diabetic patients often blunt the febrile response. Tachycardia + fluid overload also needs its own workup (anemia, access recirculation/high-output state, uremic pericarditis, catheter-related bacteremia).

Likely differential for the back pain

Category	Consideration
Infective	Catheter-related bloodstream infection with hematogenous seeding → vertebral discitis/osteomyelitis (permacath is the key risk factor here)
CKD-MBD	Secondary/tertiary hyperparathyroidism, renal osteodystrophy, adynamic bone disease
Structural	Osteoporotic/compression vertebral fracture (common in long-standing CKD5)
Hematologic	Multiple myeloma (always rule out in a 60-yr-old with bone pain + renal failure)
Amyloid	Dialysis-related β2-microglobulin amyloidosis (>5 yrs on HD, but worth flagging)
Mechanical	Simple musculoskeletal strain (diagnosis of exclusion here)

Per Comprehensive Clinical Nephrology and general dialysis access literature (Fischer's Mastery of Surgery; Goldman-Cecil), a tunneled catheter with unexplained systemic symptoms (even afebrile, with tachycardia) warrants blood cultures from the catheter and periphery before anything else — catheter-related bacteremia is a leading cause of hospitalization/mortality in HD patients, and a recent meta-analysis (PMID 38536779, 2024) found diabetes, low hemoglobin, and elevated CRP/procalcitonin as key risk markers for catheter-associated bloodstream infection — all of which fit this patient.

Investigations to order

Urgent/first-line

CBC, peripheral smear, CRP, procalcitonin (if available)
Blood cultures — one from permacath lumen, one peripheral (paired) — before starting antibiotics
Serum electrolytes, corrected calcium, phosphorus, intact PTH, ALP, 25-OH vitamin D
ECG (tachycardia workup, look for uremic pericarditis changes)
2D-Echo (fluid status, EF, pericardial effusion, high-output state from AVF)
Chest X-ray (fluid overload, cardiomegaly)
X-ray lumbosacral spine
MRI spine (non-contrast, or with low-dose non-gadolinium contrast if gadolinium risk of NSF a concern) if X-ray inconclusive and infection/discitis suspected — this is the definitive test if osteomyelitis/discitis is on the table
Doppler ultrasound of the AV fistula (rule out stenosis, aneurysm, steal, or access-related high flow contributing to tachycardia)
TSH (tachycardia work-up)
Serum protein electrophoresis + serum free light chains/UPEP (myeloma screen, given age and CKD)
Iron profile (ferritin, TSAT), CRP for anemia/ESA responsiveness
Dialysis adequacy: Kt/V or URR, review of dry weight and inter-dialytic weight gain

Medication plan (Indian brands) — pending investigation results

1. Pain (safe, renally-adjusted; avoid NSAIDs entirely – fluid retention, GI/cardiac risk, no renal excretion benefit since anuric)

Paracetamol – Dolo 650 (Micro Labs), 500-650 mg QID PRN, max 2-3 g/day — first-line for musculoskeletal pain
If inadequate: Tramadol 50 mg, reduced frequency (BD instead of QID) — Tramazac (Sun Pharma) / Ultracet (paracetamol+tramadol, Janssen) — extend dosing interval in ESRD
Avoid morphine/codeine (active metabolite accumulation in renal failure); if severe pain and infection excluded, low-dose Gabapentin 100 mg post-dialysis only — Gabapin (Intas), titrate very cautiously

2. If catheter-related bacteremia confirmed/suspected (empiric, pending culture)

IV Vancomycin, renally dosed by trough level, given post-HD — e.g., Vancomycin injection (Cipla/generic)
Plus Gram-negative cover per local antibiogram, e.g., IV Cefepime or Amikacin, dose-adjusted and given post-dialysis
Nephrology/surgical review for catheter exchange or removal if cultures grow Pseudomonas, MRSA, or Candida

3. Hypertension + tachycardia

Continue/optimize Amlodipine – Amlong (Micro Labs) 5-10 mg OD (no renal adjustment needed)
Add cardioselective beta-blocker to address tachycardia + BP — Metoprolol succinate – Met XL (Sun Pharma) 25-50 mg OD, useful in fluid-overloaded HD patients
Telmisartan – Telma (Glenmark) 40 mg OD only if potassium is monitored and not elevated

4. Type 2 Diabetes (in HD/CKD5)

Avoid metformin and most sulfonylureas (hypoglycemia risk)
Insulin is mainstay — Human Insulin/Insugen (Biocon) or Insulin Glargine – Basalog (Biocon), start low and titrate (insulin clearance is reduced in ESRD)
Linagliptin – Trajenta (Boehringer Ingelheim India) 5 mg OD, no renal dose adjustment needed, safe adjunct

5. Fluid overload

Reinforce fluid (750 ml–1 L/day) and salt restriction
Reassess and lower dry weight at next HD sessions; consider an extra ultrafiltration session if significantly overloaded
If any residual urine output: high-dose Torsemide – Dytor (Cipla) 50-100 mg OD, otherwise diuretics have no role in anuric ESRD

6. CKD-MBD (pending PTH/Ca/PO4 results)

If hyperphosphatemia: Sevelamer carbonate — Renvia/Sevelamer (Cipla) with meals; or Calcium carbonate – Shelcal (Torrent) if not hypercalcemic
If elevated PTH with low/normal calcium: Calcitriol – Calcirol/Rocaltrol (Cipla) post-HD dosing
If severe secondary hyperparathyroidism: Cinacalcet – Cinacet (Sun Pharma) 30 mg OD, titrate per calcium/PTH

7. Anemia (very likely contributing to tachycardia — check Hb first)

Erythropoietin — Epofer (Emcure) / Epogen, dosed per Hb target 10-11.5 g/dL
IV iron sucrose — Orofer S, given during dialysis sessions (avoid oral iron, poorly absorbed in ESRD)

Bottom line

Do not commit to a pain-only prescription until blood cultures, inflammatory markers, PTH/calcium/phosphate, and spine imaging come back — the permacath plus afebrile tachycardia plus new back pain combination is exactly the pattern in which catheter-related bacteremia with vertebral seeding gets missed. All drug doses above assume anuric CKD-5/HD status and need individualization by the treating nephrologist based on actual labs, dialysis schedule, and current weight — this is a framework, not a substitute for bedside clinical judgment.

This is a shared conversation. Sign in to Orris to start your own chat.